Document Type
Erratum
Publication Date
10-1-2019
Description
The authors regret the order and address of corresponding authors of the original article were given incorrectly. The correct order of all authors is as follows: Jie Weng1, Mengyun Tu1, Peng Wang, Xiaoming Zhou, Chuanyi Wang, Xinlong Wan, Zhiliang Zhou, Liang Wang, Xiaoqun Zheng, Junjian Li, Chan Chen**, Zhiyi Wang**, Zhibin Wang*. The correct corresponding author at: Institute of Bioscaffold Transplantation and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, China. This reflects the fact that Zhibin Wang was the main contributing corresponding author to the original article. The authors would like to apologise for any inconvenience caused.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Citation Information
Weng, Jie; Tu, Mengyun; Wang, Peng; Zhou, Xiaoming; Wang, Chuanyi; Wan, Xinlong; Zhou, Zhiliang; Wang, Liang; Zheng, Xiaoqun; Li, Junjian; Chen, Chan; Wang, Zhiyi; and Wang, Zhibin. 2019. Corrigendum to “Amiodarone Induces Cell Proliferation and Myofibroblast Differentiation via ERK1/2 and p38 MAPK Signaling in Fibroblasts” (Biomedicine & Amp; Pharmacotherapy (2019) 115, (S0753332218378752), (10.1016/j.biopha.2019.108889)). Biomedicine and Pharmacotherapy. Vol.118 https://doi.org/10.1016/j.biopha.2019.109085 PMID: 31178264 ISSN: 0753-3322
Copyright Statement
© 2019 The Author(s). Published by Elsevier Masson SAS.